These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 24051171

  • 1. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
    Gulia S, Bajpai J, Gupta S, Maheshwari A, Deodhar K, Kerkar RA, Seth V, Rekhi B, Menon S.
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
    [Abstract] [Full Text] [Related]

  • 2. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    Alifrangis C, Agarwal R, Short D, Fisher RA, Sebire NJ, Harvey R, Savage PM, Seckl MJ.
    J Clin Oncol; 2013 Jan 10; 31(2):280-6. PubMed ID: 23233709
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ, Zhang GN.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug 10; 47(8):571-6. PubMed ID: 23141175
    [Abstract] [Full Text] [Related]

  • 4. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR, Schink JC.
    J Reprod Med; 2012 Aug 10; 57(5-6):219-24. PubMed ID: 22696816
    [Abstract] [Full Text] [Related]

  • 5. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C, Pautier P, Duvillard P, Floquet A, Kerbrat P, Troalen F, Rey A, Balleyguier C, Tazi Y, Leary A, Augereau P, Morice P, Droz JP, Fizazi K, Lhommé C.
    Eur J Cancer; 2014 Aug 10; 50(12):2082-9. PubMed ID: 24910417
    [Abstract] [Full Text] [Related]

  • 6. Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide.
    Han SN, Amant F, Leunen K, Devi UK, Neven P, Berteloot P, Vergote I.
    Gynecol Oncol; 2012 Oct 10; 127(1):47-50. PubMed ID: 22705360
    [Abstract] [Full Text] [Related]

  • 7. A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.
    Faaborg L, Niemann I, Ostenfeld EB, Hansen ES, Sunde L, Lindegaard JC.
    Acta Oncol; 2016 Oct 10; 55(2):234-9. PubMed ID: 26106854
    [Abstract] [Full Text] [Related]

  • 8. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T, Chen LL, Qin JL, Wang XY, Cheng XD, Xie X, Lyu WG.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun 25; 53(6):371-376. PubMed ID: 29961278
    [Abstract] [Full Text] [Related]

  • 9. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.
    Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, Kose MF.
    Int J Gynecol Cancer; 2006 Jun 25; 16(3):1432-8. PubMed ID: 16803542
    [Abstract] [Full Text] [Related]

  • 10. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM, Desai A.
    J Reprod Med; 2010 Jun 25; 55(7-8):296-300. PubMed ID: 20795341
    [Abstract] [Full Text] [Related]

  • 11. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
    Essel KG, Bruegl A, Gershenson DM, Ramondetta LM, Naumann RW, Brown J.
    Gynecol Oncol; 2017 Jul 25; 146(1):74-80. PubMed ID: 28473205
    [Abstract] [Full Text] [Related]

  • 12. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
    Lybol C, Thomas CM, Blanken EA, Sweep FC, Verheijen RH, Westermann AM, Boere IA, Reyners AK, Massuger LF, van Hoesel RQ, Ottevanger PB.
    Eur J Cancer; 2013 Mar 25; 49(4):860-7. PubMed ID: 23099004
    [Abstract] [Full Text] [Related]

  • 13. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
    Escobar PF, Lurain JR, Singh DK, Bozorgi K, Fishman DA.
    Gynecol Oncol; 2003 Dec 25; 91(3):552-7. PubMed ID: 14675675
    [Abstract] [Full Text] [Related]

  • 14. Gestational Trophoblastic Neoplasia: Experience from a Tertiary Care Center of India.
    Hussain A, Aziz SA, Bhatt GM, Lone AR, Hussain HI, Wani B, Qazi N.
    J Obstet Gynaecol India; 2016 Dec 25; 66(6):404-408. PubMed ID: 27821978
    [Abstract] [Full Text] [Related]

  • 15. Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.
    Eiriksson L, Wells T, Steed H, Schepansky A, Capstick V, Hoskins P, Pike J, Swenerton K.
    Gynecol Oncol; 2012 Mar 25; 124(3):553-7. PubMed ID: 22079360
    [Abstract] [Full Text] [Related]

  • 16. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V, Szigetvári I, Szepesi J, Végh G, Singh M, Berkowitz RS.
    J Reprod Med; 2012 Mar 25; 57(7-8):310-8. PubMed ID: 22838247
    [Abstract] [Full Text] [Related]

  • 17. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H, Soudy H, Darwish A, Ahmed M, Eltigani A, Edesa W, Elhassan T, Omar A, Elghamry W, Al-Hashem H, Al-Hayli S, Madkhali I, Ahmad S, Al-Badawi IA.
    Clin Transl Oncol; 2015 May 25; 17(5):409-15. PubMed ID: 25398721
    [Abstract] [Full Text] [Related]

  • 18. Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary.
    Fülöp V, Szigetvári I, Szepesi J, Végh G, Berkowitz RS.
    J Reprod Med; 2014 May 25; 59(5-6):227-34. PubMed ID: 24937962
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
    Deng L, Zhang J, Wu T, Lawrie TA.
    Cochrane Database Syst Rev; 2013 Jan 31; 2013(1):CD005196. PubMed ID: 23440800
    [Abstract] [Full Text] [Related]

  • 20. Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
    Savage P, Cooke R, O'Nions J, Krell J, Kwan A, Camarata M, Dancy G, Short D, Seckl MJ, Swerdlow A.
    J Clin Oncol; 2015 Feb 10; 33(5):472-8. PubMed ID: 25547507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.